Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Lactulose
- Therapeutic area
- Gastrointestinal & hepatology
- Drug class
- Laxatives
- ATC
- A06
- Strength
- 3.35 mg/5 mL
- Dosage form
- Syrup
- Pack
- 120ML
- Registration no.
- 067918
- Price record verified
- 2026-08-24
- Latest DRAP source check
- 2026-11-13 03:02
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →What EVERLOSE (Lactulose) is used for
Lactulose is a laxative, a medicine that helps you pass stools (poo). It is a man-made sugar that comes as a sweet syrup or liquid to swallow. Very little of it is absorbed into the body. Instead, it is broken down in the bowel into substances that draw water in, which softens the stools and makes them easier to pass. This type is called an osmotic laxative. In people with severe liver disease, it also helps remove toxins such as ammonia from the blood through the bowel. It can be bought from pharmacies and is also prescribed by doctors.
- Constipation (passing stools less often, or stools that are hard and dry)
- Constipation after surgery, as it is gentler on the gut than some other laxatives
- Hepatic encephalopathy: confusion, shaking, sleepiness or coma caused by severe liver disease, where it helps clear toxins that build up when the liver is failing. This use is under a doctor's care.
Get medical help straight away if
- Call an ambulance or go to the emergency department for signs of a severe allergic reaction: swelling of the lips, mouth, tongue or throat, wheezing or struggling to breathe, a tight throat, skin or lips turning blue, grey or pale, sudden confusion or fainting, or a swollen, blistered or peeling rash.
- Contact a doctor straight away if you have severe diarrhoea or vomiting that goes on, together with muscle cramps or weakness or an uneven heartbeat. These can be signs that the body's salts (sodium, potassium, magnesium) are out of balance.
- US advice (MedlinePlus) is to stop taking it and call your doctor straight away if you get stomach pain or cramps, or vomiting. NHS advice is to speak to a pharmacist or doctor if stomach pain is severe.
- If you have taken too much and have bad diarrhoea or stomach pain, stop taking it and contact a doctor or pharmacist straight away.
Side effects, warnings and interactions for Lactulose
Prepared from the sources listed by the MedInfoBase team. General information, not medical advice: it gives no doses. Your doctor or pharmacist decides the medicine and dose for you.
Our condition guides that mention Lactulose
From our condition guides, written from WHO, NICE and other opened sources. Your doctor decides if Lactulose is right for you and the dose.
- Anaemia in pregnancy: may help if iron tablets cause constipation, alongside more fibre and fluids
- Constipation: Usually first choice when diet changes are not enough
- Piles (haemorrhoids): Keep stools soft so you do not need to strain, which helps piles heal and stops them coming back
- Irritable bowel syndrome (IBS): UK guidance advises against using this laxative in IBS
About EVERLOSE 3.35 mg/5 mL syrup
EVERLOSE 3.35 mg/5 mL syrup contains Lactulose 3.35 mg/5 mL. It is registered with DRAP by Allmed (Pvt.) Ltd (registration no. 067918). Its official price is PKR 315.63 for a pack of 120ML. The price changed from PKR 300.77 to PKR 315.63 on 19 August 2026. 2 other brands of Lactulose 3.35 mg/5 mL (syrup) are registered in Pakistan. Compare all brands and prices →
All 2 other brands of Lactulose 3.35 mg/5 mL syrup in Pakistan
These 2 brands are alternatives (substitutes) to EVERLOSE: each contains Lactulose 3.35 mg/5 mL syrup. Ask your doctor or pharmacist before you switch brands.
Sorted by price per mL, lowest first. The lowest is Lactogiz Syp (Glitz Pharma) at PKR 2.32 per mL; the highest is Laxocare at PKR 2.55. All prices are official DRAP prices.
| Brand | Company | Pack | Official price | Per unit |
|---|---|---|---|---|
| Lactogiz Syp | Glitz Pharma | 120ml | PKR 278.98 | PKR 2.32 / mL |
| Laxocare | Martin Dow Marker Limited | 120ml | PKR 305.67 | PKR 2.55 / mL |
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for EVERLOSE, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- Allmed (Pvt.) Ltd, Lahore
- DRAP registration
- 067918
- Phone
- +92 21 34943800
- info@allmed.com.pk
- Website
- https://allmed.com.pk/
- Contact page
- Company contact page
Contact details as published by the company, last checked on 21 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
PKR 300.77 to 315.63 (+4.9%) between 22 Aug 2025 and 19 Aug 2026 · 2 official price records · pack 120ML
Step chart: a notified price holds until DRAP notifies the next one. Hover or tap a point for its date and change.
Cite this price history
MedInfoBase. EVERLOSE 3.35 mg/5 mL, 120ML: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/everlose-3-35-mg-5-ml-067918-120ml-allmed-pvt-ltd/ (accessed 13 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 315.63 | 2026-08-19 | 2026-08-24 | DRAP PharmaPrice Index | Current |
| PKR 300.77 | 2025-08-22 | 2026-08-08 | DRAP PharmaPrice Index | Historical |
Cite this record
Medicine record · DRAP registration 067918Price and registration data on this page were observed on 24 August 2026. Records change over time, so please cite the observation date alongside the access date.